Table of Contents

WSJ News Exclusive | Pfizer in Early-Stage Talks to Acquire Seagen


Pfizer Inc. is in talks to acquire biotech Seagen Inc, according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted cancer therapies.


Related Articles

Scroll to Top